Whitestone REIT (NYSE: WSR) ("Whitestone" or the "Company") today announced its operating and financial results for the second quarter and year-to-date of 2025.

Pulmonx Corporation (Nasdaq: LUNG) ('Pulmonx” or the 'Company'), a global leader in minimally invasive treatments for lung ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2025 financial results.

For the quarter ended June 30, 2025, LXP generated Adjusted Company FFO of $47.3 million, or $0.16 per diluted share, compared to Adjusted Company FFO for the quarter ended June 30, 2024 of $46.9 ...